Among the most important changes in the regulation of the Russian pharmaceutical industry in the 2nd quarter of 2023, are the following:
:
Among the most important changes in the regulation of foreign economic activity in the 1st quarter of 2023, the following can be distinguished:
Roman Shabrov, partner at BRACE commented for Pharmaceutical Bulletin magazine on the case of an anti-competitive agreement on the Chlorhexedine antiseptic market, identified by the FAS Russia, the resolution of which was appealed by the companies held liable.
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 1st quarter of 2023, the following can be distinguished:
In July 2021, the Eurasian Economic Commission issued an update that from July 1, 2021, medicinal products should be registered according to the unified rules of the EAEU. These rules were approved by the Decision of the Council of the Economic Commission dated 03.01.2017 No. 78 “On the rules for registration and examination of medicines for medical use”. At the same time, for the Russian Federation, the establishment of compulsory registration under the EAEU Rules was carried out from January 1, 2021.
- The Ministry of Health has allowed the use of personal medicines of patients in inpatient treatment
- Simplified medicinal product labeling procedure is prolonged
- A new regulation on state control of medicinal products circulation
- New rules for the import of medicinal products into the territory of Russia have been adopted
Earlier articles
Latest news
Digest of the Russian pharmaceutical industry in the 2nd quarter of 2023
28-07-2023
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 2nd quarter of 2023, are the following: :
Digest of regulation of international trade in Russia in the 1st quarter of 2023
17-05-2023
Among the most important changes in the regulation of foreign economic activity in the 1st quarter of 2023, the following can be distinguished:
Digest of the Russian pharmaceutical industry in the 1st quarter of 2023
12-05-2023
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 1st quarter of 2023, the following can be distinguished:
Roman Shabrov, attorney at law and partner at BRACE commented on the case of an anticompetitive agreement in the antiseptic market
21-02-2022
Roman Shabrov, partner at BRACE commented for Pharmaceutical Bulletin magazine on the case of an anti-competitive agreement on the Chlorhexedine antiseptic market, identified by the FAS Russia, the resolution of which was appealed by the companies held liable.
The Eurasian Economic Commission recalls the registration of medicines according to the rules of the EAEU
11-08-2021
In July 2021, the Eurasian Economic Commission issued an update that from July 1, 2021, medicinal products should be registered according to the unified rules of the EAEU. These rules were approved by the Decision of the Council of the Economic Commission dated 03.01.2017 No. 78 “On the rules for registration and examination of medicines for medical use”. At the same...
The Ministry of Health has allowed the use of personal medicines of patients in inpatient treatment
11-08-2021
Recall that earlier by Appendix No. 5 to the Rules of Compulsory Medical Insurance, approved by order of the Ministry of Health of the Russian Federation No. 108n dated February 28, 2019, determining the coefficients of the amount of non-payment or incomplete payment of the costs of a medical organization for the provision of medical care as a basis for...